IL-2 R beta & IL-2 R gamma

IL-2 R beta & IL-2 R gamma 詳細

英語名Interleukin-2 receptor subunit gamma市販薬剤の数0
治験薬の数14ターゲットの別称Common Cytokine Receptor Gamma Chain,IL-2R Subunit Gamma,IL2RG,SCIDX,CD132,CIDX,IL-2RG,IMD4,Nonfunctional Common Cytokine Receptor Gamma Chain,Combined Immunodeficiency, X-Linked,Interleukin 2 Receptor Subunit Gamma,Interleukin-2 Receptor Subunit Gamma,Severe Combined Immunodeficiency,Cytokine Receptor Common Subunit Gamma,CD132 Antigen,GammaC,Interleukin 2 Receptor, Gamma,IL-2 Receptor Subunit Gamma,SCIDX1,P64
研究&開発段階Phase 2 Clinical
英語名Interleukin-2 receptor subunit gamma
ターゲットの別称Common Cytokine Receptor Gamma Chain,IL-2R Subunit Gamma,IL2RG,SCIDX,CD132,CIDX,IL-2RG,IMD4,Nonfunctional Common Cytokine Receptor Gamma Chain,Combined Immunodeficiency, X-Linked,Interleukin 2 Receptor Subunit Gamma,Interleukin-2 Receptor Subunit Gamma,Severe Combined Immunodeficiency,Cytokine Receptor Common Subunit Gamma,CD132 Antigen,GammaC,Interleukin 2 Receptor, Gamma,IL-2 Receptor Subunit Gamma,SCIDX1,P64
市販薬剤の数0
治験薬の数14
研究&開発段階Phase 2 Clinical

IL-2 R beta & IL-2 R gammaバックグランド

Both Interleukin-2 receptor subunit beta and Interleukin-2 receptor subunit gamma are receptor for interleukin-2. Common subunit for the receptors for a variety of interleukins. Interacts with SHB upon interleukin stimulation. Probably in association with IL15RA, involved in the stimulation of neutrophil phagocytosis by IL15. This beta subunit is involved in receptor mediated endocytosis and transduces the mitogenic signals of IL2. IL2R exists in 3 different forms: a high affinity dimer, an intermediate affinity monomer (beta subunit), and a low affinity monomer (alpha subunit). The high and intermediate affinity forms also associate with a gamma subunit.

IL-2 R beta & IL-2 R gamma分子の別称

IL-2 R beta & IL-2 R gamma,IL-2RB & IL-2RG

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
MB-107IND-14570; MB-107Phase 2 ClinicalNational Heart, Lung And Blood Institute, National Institute Of Allergy And Infectious Diseases (Niaid), National Institute of Health, Islamabad, St. Jude Children'S Research HospitalImmunologic Deficiency Syndromes; X-Linked Combined Immunodeficiency Diseases
詳細
AWT-020AWT020; AWT-020; JS213; JS-213Phase 2 ClinicalAnwita Biosciences IncAutoimmune Diseases of the Nervous System; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Lung Neoplasms; Melanoma; Neoplasms; Solid tumours
詳細
GI-101SIM-323; SIM323; SIM0323; GI-101Phase 2 ClinicalGI Innovation IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Neoplasms; Solid tumours; Uterine Cervical Neoplasms
詳細
MB-501MB501; MB-501Phase 2 ClinicalAscendis Pharma IncNeoplasms
詳細
PegenzileukinIBI-127; THOR-707; SAR-444245Phase 2 ClinicalSynthorx IncCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colorectal Neoplasms; Esophageal adenocarcinoma; Esophageal Squamous Cell Carcinoma; Head and Neck Neoplasms; Hodgkin Disease; Intestinal Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma; Mesothelioma; Multiple Myeloma; Neoplasm Metastasis; Oropharyngeal Neoplasms; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms
詳細
LTC-004LTC004; LTC-004Phase 2 ClinicalLeto Laboratories Co LtdColorectal Neoplasms; Neoplasms; Pancreatic Neoplasms; Sarcoma; Solid tumours
詳細
TransCon IL-2 β/γPhase 2 ClinicalAscendis Pharma A/SCarcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Ovarian Neoplasms; Solid tumours
詳細
TYF-IL-2Rg gene-modified autologous stem cells (Shenzhen Geno-Immune Medical Institute)Phase 2 ClinicalShenzhen Geno-Immune Medical InstituteX-Linked Combined Immunodeficiency Diseases
詳細
Simlukafusp alfaFAP-IL2v; RG-7461; aFAP-IL2v; RO-6874281; FAP-IL2v FPPhase 1 ClinicalF. Hoffmann-La Roche LtdBreast Neoplasms; Carcinoma, Renal Cell; Esophageal Neoplasms; Head and Neck Neoplasms; Melanoma; Solid tumours; Uterine Cervical Neoplasms
詳細
BJ-001(Boji Biomedical Technology)BJ-001Phase 1 ClinicalBoji Biomedical Technology (Hangzhou) Co LtdCommunicable Diseases; Neoplasm Metastasis; Solid tumours
詳細
ex vivo IL2RG stem cell-based gene therapy (Genethon/University College London/Hannover Medical School)Phase 1 ClinicalGenethonSevere Combined Immunodeficiency
詳細
PD 1-proIL-2v (Proviva Therapeutics)PTX-912Phase 1 ClinicalProviva Therapeutics IncNeoplasm Metastasis; Neoplasms; Solid tumours
詳細
NL-201 (Neoleukin Therapeutics)NL-201Phase 1 ClinicalNeoleukin Therapeutics IncSolid tumours
詳細
Recombinant human interleukin 15(Beijing Kawin)Phase 1 ClinicalBeijing Kawin Technology Share-Holding Co LtdSolid tumours
詳細

レビュー

  • 詳細
  • 製品リスト
  • レビュー
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8